Skip to main content
Top
Published in: Journal of Clinical Immunology 3/2008

01-05-2008

Interleukin-10 and Tumor Necrosis Factor-α Gene Polymorphisms in Tuberculosis

Authors: Ö. Ates, B. Musellim, G. Ongen, A. Topal-Sarıkaya

Published in: Journal of Clinical Immunology | Issue 3/2008

Login to get access

Abstract

Tuberculosis (TB), caused by Mycobacterium tuberculosis, is an infectious disease in humans killing nearly three million people and eight million cases annually. The cytokines TNF-α and IL-10 have been implicated in the pathogenesis of TB. Certain single nucleotide polymorphisms within the promoter region of the IL10 and TNF genes have been associated with altered levels of circulating IL10 and TNF- α. We analyzed TNF-α (−308 G/A, −238 G/A, −376 G/A) and IL10 (−1,082 G/A, −819 C/T, −592 C/A) polymorphisms in 128 patients with TB and 80 healthy subjects using by amplification refractory mutation system-polymerase chain reaction (ARMS-PCR). A significant association was found between TB and −1,082 G allele (Pc: 0.000, O.R 2.22, 95% CI 1.45–3.41). Significant difference was observed in IL10 GCC and ACC haplotypes distribution between TB and control subjects (Pc: 0.000, O.R 2.22, 95% CI 1.45–3.41; Pc: 0.004, O.R 0.53, 95% CI 0.35–0.81). No statistically significant association was found between IL-10 −819 C/T, TNF-α 308 G/A, −238 G/A, −376 G/A polymorphisms, functional TNFα/IL-10 genotypes and TB. Our findings suggest that IL-10 108 2G/A alleles or haplotypes containing these alleles may influence the Th1/Th2 balance and hence may play a role in TB susceptibility and increase risk of developing disease. This polymorphism may be one of the many genetic factors affecting disease outcome.
Literature
1.
go back to reference Raviglione M, Snider D, Kochi A. Global epidemiology of tuberculosis. Mortality and morbidity of a worldwide epidemic. JAMA. 1995;273:220–6.PubMedCrossRef Raviglione M, Snider D, Kochi A. Global epidemiology of tuberculosis. Mortality and morbidity of a worldwide epidemic. JAMA. 1995;273:220–6.PubMedCrossRef
2.
go back to reference Sılva CL, Bonato VLD, Lıma KM, Coelho-Castelo AAM, Faccıolı LH, Sartorı A, et al. Cytotoxic T cells and mycobacteria. FEMS Microbiol Lett. 2001;197:11–8.PubMedCrossRef Sılva CL, Bonato VLD, Lıma KM, Coelho-Castelo AAM, Faccıolı LH, Sartorı A, et al. Cytotoxic T cells and mycobacteria. FEMS Microbiol Lett. 2001;197:11–8.PubMedCrossRef
3.
go back to reference Van Deventer SJH. Cytokine and cytokine receptor polymorphisms in infectious disease. Intensive Care Med. 2000;26:98–102.CrossRef Van Deventer SJH. Cytokine and cytokine receptor polymorphisms in infectious disease. Intensive Care Med. 2000;26:98–102.CrossRef
4.
go back to reference De Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med. 1991;174:1209–20.PubMedCrossRef De Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med. 1991;174:1209–20.PubMedCrossRef
5.
go back to reference Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O’Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol. 1991;146:3445–51. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O’Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol. 1991;146:3445–51.
6.
go back to reference Takeshita S, Gage JR, Kishimoto T, Vredevoe DL, Martinez-Maza O. Differential regulation of IL-6 gene transcription and expression by IL-4 and Il-10 in human monocytic cell lines. J Immunol. 1996;156:2591–98.PubMed Takeshita S, Gage JR, Kishimoto T, Vredevoe DL, Martinez-Maza O. Differential regulation of IL-6 gene transcription and expression by IL-4 and Il-10 in human monocytic cell lines. J Immunol. 1996;156:2591–98.PubMed
7.
go back to reference Knight J. Polymorphisms in tumor necrosis factor and other cytokines as risks for infectious diseases and the septic syndrome. Curr Infect Dis Rep. 2001;3:427–39.PubMedCrossRef Knight J. Polymorphisms in tumor necrosis factor and other cytokines as risks for infectious diseases and the septic syndrome. Curr Infect Dis Rep. 2001;3:427–39.PubMedCrossRef
8.
go back to reference Westendorp RG, Langermans JA, Huizinga TW, Elouali AH, Verveij CL, Boomsma DI, et al. Genetic influence on cytokine production and fatal meningococcal disease. Lancet. 1997;349:170–73.PubMedCrossRef Westendorp RG, Langermans JA, Huizinga TW, Elouali AH, Verveij CL, Boomsma DI, et al. Genetic influence on cytokine production and fatal meningococcal disease. Lancet. 1997;349:170–73.PubMedCrossRef
9.
go back to reference Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215.PubMedCrossRef Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215.PubMedCrossRef
10.
go back to reference Perrey C, Turner SJ, Pravica V, Howell WM, Hutchinson IV. ARMS-PCR methodologies to determine IL-10, TNF-α, TNF-β and TGF-β1 gene polymorphisms. Transpl Immunol. 1999;7:127–8.PubMedCrossRef Perrey C, Turner SJ, Pravica V, Howell WM, Hutchinson IV. ARMS-PCR methodologies to determine IL-10, TNF-α, TNF-β and TGF-β1 gene polymorphisms. Transpl Immunol. 1999;7:127–8.PubMedCrossRef
11.
go back to reference Richardson A, Sisay-Joof F, Ackerman H, Usen S, Katundu P, Taylor T, et al. Nucleotide diversity of the TNF gene region in an African village. Genes Immun. 2001;2:343–8.PubMedCrossRef Richardson A, Sisay-Joof F, Ackerman H, Usen S, Katundu P, Taylor T, et al. Nucleotide diversity of the TNF gene region in an African village. Genes Immun. 2001;2:343–8.PubMedCrossRef
12.
go back to reference Delgado JC, Baena A, Thim S, Goldfeld AE. Ethnic-specific genetic associations with pulmonary tuberculosis. J Infect Dis. 2002;186:1463–8.PubMedCrossRef Delgado JC, Baena A, Thim S, Goldfeld AE. Ethnic-specific genetic associations with pulmonary tuberculosis. J Infect Dis. 2002;186:1463–8.PubMedCrossRef
13.
go back to reference Oh JH, Yang CS, Noh YK, Kweon YM, Jung SS, Son JW, Kong SJ, Yoon J, Lee JS, Kım HJ, Park JK, Jo EK, Song CH. Polymorphisms of interleukin-10 and tumour necrosis factor-α genes are associated with newly diagnosed and recurrent pulmonary tuberculosis. Respirology. 2007;12:594–98.PubMedCrossRef Oh JH, Yang CS, Noh YK, Kweon YM, Jung SS, Son JW, Kong SJ, Yoon J, Lee JS, Kım HJ, Park JK, Jo EK, Song CH. Polymorphisms of interleukin-10 and tumour necrosis factor-α genes are associated with newly diagnosed and recurrent pulmonary tuberculosis. Respirology. 2007;12:594–98.PubMedCrossRef
14.
go back to reference Bellamy R, Ruwende C, Corrah T, McAdam KP, Whittle HC, Hill AV. Assessment of the interleukin 1 gene cluster and other candidate gene polymorphisms in host susceptibility to tuberculosis. Tuber Lung Dis 1998;79:83−9.PubMedCrossRef Bellamy R, Ruwende C, Corrah T, McAdam KP, Whittle HC, Hill AV. Assessment of the interleukin 1 gene cluster and other candidate gene polymorphisms in host susceptibility to tuberculosis. Tuber Lung Dis 1998;79:83−9.PubMedCrossRef
15.
go back to reference Lopez-Maderuelo D, Arnalich F, Serantes R, Gonzalez A, Codocen R, Madero R, Vazquez JJ, Montiel C. Interferon-gamma and interleukin-10 gene polymorphisms in pulmonary tuberculosis. Am J Respir Crit Care Med 2003;167:970−5.PubMedCrossRef Lopez-Maderuelo D, Arnalich F, Serantes R, Gonzalez A, Codocen R, Madero R, Vazquez JJ, Montiel C. Interferon-gamma and interleukin-10 gene polymorphisms in pulmonary tuberculosis. Am J Respir Crit Care Med 2003;167:970−5.PubMedCrossRef
16.
go back to reference Tso HW, Ip WK, Chong WP, Tam CM, Chiang AKS, Lau YL. Association of interferon gamma and interleukin 10 genes with tuberculosis in Hong Kong Chinese. Genes Immun. 2005;6:358–63.PubMedCrossRef Tso HW, Ip WK, Chong WP, Tam CM, Chiang AKS, Lau YL. Association of interferon gamma and interleukin 10 genes with tuberculosis in Hong Kong Chinese. Genes Immun. 2005;6:358–63.PubMedCrossRef
17.
go back to reference Shın HD, Park BL, Kım YH, Cheong HS, Lee IH, Park SK. Common interleukin 10 polymorphism associated with decreased risk of tuberculosis. Exp Mol Med. 2005;37(2):128–32.PubMed Shın HD, Park BL, Kım YH, Cheong HS, Lee IH, Park SK. Common interleukin 10 polymorphism associated with decreased risk of tuberculosis. Exp Mol Med. 2005;37(2):128–32.PubMed
18.
go back to reference Oral HB, Ferah B, Uzaslan EK, Basturk B, Bekar A, Akalın H, Ege E, Ener B, Goral G. Interleukin-10 (IL-10) gene polymorphism as a potential host susceptibility factor in tuberculosis. Cytokine 2006;35:6143–7.CrossRef Oral HB, Ferah B, Uzaslan EK, Basturk B, Bekar A, Akalın H, Ege E, Ener B, Goral G. Interleukin-10 (IL-10) gene polymorphism as a potential host susceptibility factor in tuberculosis. Cytokine 2006;35:6143–7.CrossRef
19.
go back to reference Koss K, Fanning GC, Welsh KI, Jewell DP. Interleukin-10 gene promoter polymorphism in English and Polish healthy controls. Polymerase chain reaction haplotyping using 3′ mismatches in forward and reverse primers. Genes Immun. 2000;1:321–24.PubMedCrossRef Koss K, Fanning GC, Welsh KI, Jewell DP. Interleukin-10 gene promoter polymorphism in English and Polish healthy controls. Polymerase chain reaction haplotyping using 3′ mismatches in forward and reverse primers. Genes Immun. 2000;1:321–24.PubMedCrossRef
20.
go back to reference Reynard MP, Turner D, Navarrete CV. Allele frequencies of polymorphisms of the tumor necrosis-alpha, interleukin-10, interferon-gamma and interleukin-2 genes in a North European Caucasoid group from the UK. Eur J Immunogenet. 2000;27:241–9.PubMedCrossRef Reynard MP, Turner D, Navarrete CV. Allele frequencies of polymorphisms of the tumor necrosis-alpha, interleukin-10, interferon-gamma and interleukin-2 genes in a North European Caucasoid group from the UK. Eur J Immunogenet. 2000;27:241–9.PubMedCrossRef
21.
go back to reference Hoffmann SC, Stanley EM, Cox ED, DiMercurio BS, Koziol DE, Harlan DM, et al. Ethnicity greatly influences cytokine gene polymorphism distribution. Am J Transplant. 2002;2:560–7.PubMedCrossRef Hoffmann SC, Stanley EM, Cox ED, DiMercurio BS, Koziol DE, Harlan DM, et al. Ethnicity greatly influences cytokine gene polymorphism distribution. Am J Transplant. 2002;2:560–7.PubMedCrossRef
22.
go back to reference Mok CC, Lanchbury JS, Chan DW, Lau SC. Interleukin 10 promoter polymorphisms in southern Chinese patients with systemic lupus erythematosus. Arthritis Rheum. 1998;41:1090–5.PubMedCrossRef Mok CC, Lanchbury JS, Chan DW, Lau SC. Interleukin 10 promoter polymorphisms in southern Chinese patients with systemic lupus erythematosus. Arthritis Rheum. 1998;41:1090–5.PubMedCrossRef
23.
go back to reference Pyo CW, Hur SS, Kim YK, Choi HB, Hong YS, Kim DW, et al. Polymorphisms of IL-1B, IL-1RN, IL-2, IL-4, IL-6, IL-10, and IFN-γ genes in the Korean population. Hum Immunol. 2003;64:979–89.PubMedCrossRef Pyo CW, Hur SS, Kim YK, Choi HB, Hong YS, Kim DW, et al. Polymorphisms of IL-1B, IL-1RN, IL-2, IL-4, IL-6, IL-10, and IFN-γ genes in the Korean population. Hum Immunol. 2003;64:979–89.PubMedCrossRef
24.
go back to reference Ide A, Kawasaki E, Abiru N, Sun F, Takahashi R, Kuwahara H, et al. Genetic association between interleukin-10 gene promoter region polymorphisms and type I diabetes age-at-onset. Hum Immunol. 2002;63:690–5.PubMedCrossRef Ide A, Kawasaki E, Abiru N, Sun F, Takahashi R, Kuwahara H, et al. Genetic association between interleukin-10 gene promoter region polymorphisms and type I diabetes age-at-onset. Hum Immunol. 2002;63:690–5.PubMedCrossRef
25.
go back to reference Kroeger KM, Carville KS, Abraham LJ. The −308 tumour necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol. 1997;34:391–9.PubMedCrossRef Kroeger KM, Carville KS, Abraham LJ. The −308 tumour necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol. 1997;34:391–9.PubMedCrossRef
26.
go back to reference Amirzargar AA, Danesh AA, Khosravi F, Niknam HH, Nikbin B. Cytokines genes polymorphisms in Iranian patients with pulmonary tuberculosis. IJI. 2004;2:125–9. Amirzargar AA, Danesh AA, Khosravi F, Niknam HH, Nikbin B. Cytokines genes polymorphisms in Iranian patients with pulmonary tuberculosis. IJI. 2004;2:125–9.
27.
go back to reference Henao MI, Montes C, París SC, García LF. Cytokine gene polymorphisms in Colombian patients with different clinical presentations of tuberculosis. Tuberculosis. 2006;86:11–9.PubMedCrossRef Henao MI, Montes C, París SC, García LF. Cytokine gene polymorphisms in Colombian patients with different clinical presentations of tuberculosis. Tuberculosis. 2006;86:11–9.PubMedCrossRef
28.
go back to reference Vejbaesya S, Chıerakul N, Luangtrakool P, Sermduangprateep C. NRAMP1 and TNF-α polymorphisms and susceptibility to tuberculosis in Thais. Respirology. 2007;12:202–6.PubMedCrossRef Vejbaesya S, Chıerakul N, Luangtrakool P, Sermduangprateep C. NRAMP1 and TNF-α polymorphisms and susceptibility to tuberculosis in Thais. Respirology. 2007;12:202–6.PubMedCrossRef
29.
go back to reference Oliveıra MM, Sılva JCS, Costa JF, Amım LH, Loredo CCS, Melo H, Queıroz LF, et al. Single Nucleotide Polymorphisms (SNPs) of the TNF-a (−238/−308) gene among TB and non TB patients: susceptibility markers of TB occurrence. Jornal Brasileiro de Pneumologia 2004;30:461–67. Oliveıra MM, Sılva JCS, Costa JF, Amım LH, Loredo CCS, Melo H, Queıroz LF, et al. Single Nucleotide Polymorphisms (SNPs) of the TNF-a (−238/−308) gene among TB and non TB patients: susceptibility markers of TB occurrence. Jornal Brasileiro de Pneumologia 2004;30:461–67.
30.
go back to reference Correa PA, Gomez LM, Cadena J, Anaya JM. Autoimmunity and tuberculosis. Opposite association with TNF polymorphism. J Rheumatol. 2005;32:219–24.PubMed Correa PA, Gomez LM, Cadena J, Anaya JM. Autoimmunity and tuberculosis. Opposite association with TNF polymorphism. J Rheumatol. 2005;32:219–24.PubMed
31.
go back to reference Hill AVS, Ruwende C, McGuire W, Bellamy R, Coleman E, Ali S, Loke H, Corrah T, Snow R, Marsh K, Greenwood B, McAdam KJWP, Whittle HC, Kwiatkowski D. Association of the TNF −238 promoter polymorphism with susceptibility to tuberculosis and malaria in Africa. Hum Immunol. 1996;47:118.CrossRef Hill AVS, Ruwende C, McGuire W, Bellamy R, Coleman E, Ali S, Loke H, Corrah T, Snow R, Marsh K, Greenwood B, McAdam KJWP, Whittle HC, Kwiatkowski D. Association of the TNF −238 promoter polymorphism with susceptibility to tuberculosis and malaria in Africa. Hum Immunol. 1996;47:118.CrossRef
32.
go back to reference Lio D, Candore G, Colombo A, Colonna Romano G, Gervasi F, Marino V, Scola L, Caruso C. A genetically determined high setting of TNF-α influences immunological parameters of HLA-B8, DR3 positive subjects: implications for autoimmunity. Hum Immunol. 2001;62:705–13.PubMedCrossRef Lio D, Candore G, Colombo A, Colonna Romano G, Gervasi F, Marino V, Scola L, Caruso C. A genetically determined high setting of TNF-α influences immunological parameters of HLA-B8, DR3 positive subjects: implications for autoimmunity. Hum Immunol. 2001;62:705–13.PubMedCrossRef
33.
go back to reference Price P, Witt C, Allcock R, Sayer D, Garlepp M, Kok CC, French M, Mallal S, Christiansen F. The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases. Immunol Rev. 1999;167:257–74.PubMedCrossRef Price P, Witt C, Allcock R, Sayer D, Garlepp M, Kok CC, French M, Mallal S, Christiansen F. The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases. Immunol Rev. 1999;167:257–74.PubMedCrossRef
34.
go back to reference Kindler V, Shappino AP, Grau GE, Pignet PF, Vassali P. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell. 1989;56:731–40.PubMedCrossRef Kindler V, Shappino AP, Grau GE, Pignet PF, Vassali P. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell. 1989;56:731–40.PubMedCrossRef
35.
go back to reference Rojas M, Oliver M, Gros P, Barrera LF, Garcia LF. TNF-a and IL-10 modulate the induction of apoptosis by virulent Mycobacterium tuberculosis in murine macrophages. J Immunol. 1999;162:6122–31.PubMed Rojas M, Oliver M, Gros P, Barrera LF, Garcia LF. TNF-a and IL-10 modulate the induction of apoptosis by virulent Mycobacterium tuberculosis in murine macrophages. J Immunol. 1999;162:6122–31.PubMed
36.
go back to reference Gerard C, Bruyns C, Marchant A Abramowicz D, Vandenabeele P, Delvaux A, Fiers W, Goldman M, Velu T. Interleukin-10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxaemia. J Exp Med. 1993;177:547–50.PubMedCrossRef Gerard C, Bruyns C, Marchant A Abramowicz D, Vandenabeele P, Delvaux A, Fiers W, Goldman M, Velu T. Interleukin-10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxaemia. J Exp Med. 1993;177:547–50.PubMedCrossRef
Metadata
Title
Interleukin-10 and Tumor Necrosis Factor-α Gene Polymorphisms in Tuberculosis
Authors
Ö. Ates
B. Musellim
G. Ongen
A. Topal-Sarıkaya
Publication date
01-05-2008
Publisher
Springer US
Published in
Journal of Clinical Immunology / Issue 3/2008
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-007-9155-2

Other articles of this Issue 3/2008

Journal of Clinical Immunology 3/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.